Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 72, Issue 3, 2001, Pages 885-888

  Roberts, John R ^a   Eustis, Chad ^a   Devore, Russell ^a   Carbone, David ^a   Choy, Hak ^a   Johnson, David ^a  

^a VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CANCER STAGING; CONTROLLED STUDY; EMERGENCY SURGERY; FEMALE; HUMAN; INTUBATION; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; TRACHEOSTOMY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 0034842393     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)02836-3     Document Type: Article

References (17)

1. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
2. A randomized trial comparing perioperative chemotherapy, and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
3. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach
4. Modern thirty-day operative mortality for surgical resections in lung cancer
5. Elective pulmonary lobectomy: Factors associated with morbidity and operative mortality
6. Random versus predictable risks of mortality after thoracotomy for lung cancer
7. Hospital mortality and long-term survival after pulmonary resection in the elderly
8. Patient and hospital characteristics related to in-hospital mortality after lung cancer resection
9. Results of surgical treatment of stage I and II lung cancer
10. Prospective comparison of open and video-assisted lobectomy
11. Survival and operative risk following pneumonectomy
12. Thirty-day operative mortality for thoracotomy in lung cancer
13. A phase III comparison of best local-regional therapy with or without chemotherapy (CT) for stage IIIA T1-3N2 non-small cell lung cancer (NSCLC); preliminary results
14. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2), and IIIB non-small cell lung cancer. Mature results of Southwest Oncology Group Phase II Study
15. Standardized exercise oximetry predicts postpneumonectomy outcome
16. Invasive exercise testing in the evaluation of patients at high-risk for lung resection
17. Assessment of pulmonary complications after lung resection